Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jacot

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
International Journal of Cancer|May 27, 2023
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patientsGaia Griguolo, Vittoria Aldegheri, Michele Bottosso, et al.
Journal of Leukocyte Biology|May 4, 2020
Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancerGhita Chabab, Clément Barjon, Naoill Abdellaoui, et al.
Cancer Medicine|December 22, 2023
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept studyThomas Bardol, Zahra Eslami-S, Doryan Masmoudi, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Breast (Edinburgh, Scotland)|October 27, 2017
External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experienceGaia Griguolo, William Jacot, Eva Kantelhardt, et al.
Breast Cancer Research : BCR|February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) miceMaha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
International Journal of Cancer|May 17, 2019
Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cellsClaire Fonti, Anne Saumet, Amanda Abi-Khalil, et al.
Cancers|April 3, 2020
<i>BRCA1</i> Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast CancerWilliam Jacot, Evelyne Lopez-Crapez, Caroline Mollevi, et al.
Bulletin Du Cancer|November 25, 2015
[Granulocyte- colony stimulating factor (G-CSF) use in clinical practice in patients receiving chemotherapy for breast cancer: The Opaline Study]William Jacot, Eric-Charles Antoine, Maya Hacini, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
International Journal of Cancer|May 27, 2023
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patientsGaia Griguolo, Vittoria Aldegheri, Michele Bottosso, et al.
Journal of Leukocyte Biology|May 4, 2020
Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancerGhita Chabab, Clément Barjon, Naoill Abdellaoui, et al.
Cancer Medicine|December 22, 2023
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept studyThomas Bardol, Zahra Eslami-S, Doryan Masmoudi, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Breast (Edinburgh, Scotland)|October 27, 2017
External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experienceGaia Griguolo, William Jacot, Eva Kantelhardt, et al.
Breast Cancer Research : BCR|February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) miceMaha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
International Journal of Cancer|May 17, 2019
Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cellsClaire Fonti, Anne Saumet, Amanda Abi-Khalil, et al.
Cancers|April 3, 2020
<i>BRCA1</i> Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast CancerWilliam Jacot, Evelyne Lopez-Crapez, Caroline Mollevi, et al.
Bulletin Du Cancer|November 25, 2015
[Granulocyte- colony stimulating factor (G-CSF) use in clinical practice in patients receiving chemotherapy for breast cancer: The Opaline Study]William Jacot, Eric-Charles Antoine, Maya Hacini, et al.
Pageof 20